"Voices of the LSI" is a regular column on the LSI’s work to cultivate a diverse, equitable and inclusive climate. Savannah Williams describes her own journey as a scientist, her motivation for becoming the LSI's first director of outreach and community engagement, and her plans for this new role.

The recently FDA-approved TAK-755 treatment for a rare but potentially lethal blood disorder arose from a fundamental biological question that piqued the interest of scientist in the Ginsburg lab at U-M.